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Chickractions is required in the developing vertebrate hindbrain for the formation and
anterior–posterior patterning of the rhombomeres. FGF signaling is required in this network to upregulate
the expression of the Krox20 and Kreisler segmentation genes, but little is known of how FGF gene expression
is regulated in the hindbrain. We show that the dynamic expression of FGF3 in chick hindbrain segments and
boundaries is similar to that of the BMP antagonist, follistatin. Consistent with a regulatory relationship
between BMP signaling and FGF3 expression, we ﬁnd that an increase in BMP activity due to blocking of
follistatin translation by morpholino antisense oligonucleotides or overexpression of BMP results in strong
inhibition of FGF3 expression. Conversely, addition of follistatin leads to an increase in the level of FGF3
expression. Furthermore, the segmental inhibition of BMP activity by follistatin is required for the expression
of Krox20, Hoxb1 and EphA4 in the hindbrain. In addition, we show that the maintenance of FGF3 gene
expression requires FGF activity, suggestive of an autoregulatory loop. These results reveal an antagonistic
relationship between BMP activity and FGF3 expression that is required for correct segmental gene
expression in the chick hindbrain, in which follistatin enables FGF3 expression by inhibiting BMP activity.
© 2008 Elsevier Inc. All rights reserved.IntroductionSubdivision of the neural epithelium into domains along the
anteroposterior (AP) axis, each with a distinct regional identity, is a
crucial early phase in the development of the vertebrate nervous
system. The establishment of such subdivisions involves signals,
initially from adjacent tissues and later from within the neural
epithelium itself, that induce the spatially-restricted expression of
transcription factors that specify regional identity. Understanding
how the nervous system is patterned requires elucidation of this
regulatory network of cell signalling and transcription factors
(Lumsden and Krumlauf, 1996; Shimamura et al., 1997).
Signiﬁcant progress has been made in identifying genes that
underlie regional speciﬁcation in the hindbrain (Lumsden, 2004;
Lumsden and Krumlauf,1996; Moens and Prince, 2002). At early stages
of nervous system development, the hindbrain is subdivided along the
AP axis into a series of segments, the rhombomeres (r), each a cell
lineage-restricted compartmentwith a distinct regional identity (Fraser
et al.,1990). This segmentation of the hindbrain organises patterning of
neurons and neural crest cells in the branchial region of the head
(Graham et al., 1996; Keynes et al., 1990; Trainor and Krumlauf, 2000;
Trevarrow et al., 1990). A network of transcription factors, including
Krox20, vHnf1, Kreisler/val and Hox family members, governs thenfeld).
l rights reserved.formation and AP speciﬁcation of rhombomeres (Aragon et al., 2005;
Barrowet al., 2000;Gavalas et al., 2003;Giudicelli et al., 2003; Krumlauf
et al., 1993; Manzanares et al., 1999; Moens et al., 1998; Prince et al.,
1998; Schneider-Maunoury et al., 1997; Seitanidou et al., 1997;
Voiculescu et al., 2001) and regulates expression of members of the
Eph and Ephrin families of cell surface receptors that restrict cell
movement between adjacent segments (Cooke et al., 2001; Mellitzer
et al., 1999; Theil et al., 1998; Xu et al., 1995, 1999a). FGF signaling
proteins have been found to be involved in the upstream regulation
of this complex genetic network (Aragon et al., 2005; Bel-Vialar et al.,
2002; Marin and Charnay, 2000; Maves et al., 2002; Roy and
Sagerstrom, 2004;Walshe et al., 2002;Wiellette and Sive, 2003, 2004).
Studies in zebraﬁsh have shown that the expression of FGF3 and
FGF8 in r4 is required to upregulate Krox20 and Kreisler/val expression
in r5 aswell as establish segmentation of the r5/r6 region (Maves et al.,
2002; Walshe et al., 2002; Wiellette and Sive, 2003). Similarly, the
results of blocking or activating FGF signaling in the chick hindbrain
reveals that FGFs are required for Krox20 and Kreisler expression
(Aragon et al., 2005; Marin and Charnay, 2000). Furthermore, these
manipulations disrupted the normal expression of Hox, Eph receptor
and Ephrin genes, and resulted in the loss of hindbrain segmentation
(Marin and Charnay, 2000; Walshe et al., 2002). Although it is not
known which members of the FGF family account for this role in
hindbrain patterning in higher vertebrates, a candidate is FGF3, which
has dynamic segmental expression in the chick and mouse hindbrain
(Mahmood et al., 1995, 1996; Powles et al., 2004; Wilkinson et al.,
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otic vesicle (Alvarez et al., 2003; Leger and Brand, 2002; Mansour
et al., 1993; Maroon et al., 2002; Phillips et al., 2001; Zelarayan et al.,
2007), but as hindbrain segmentation is normal in FGF3 null
mutants (Wright andMansour, 2003) it is currently unclear whether it
also has a role within the hindbrain, perhaps acting redundantly with
other FGFs.
Studies of patterning in a number of tissues have revealed
antagonistic relationships between the FGF and BMP signaling
systems. This antagonism can regulate cell fate, such as in neural
induction when BMP signaling is necessary for epidermal cell
speciﬁcation, while FGF signaling and BMP inhibitors are both
required for ectodermal cells to acquire a neural fate (De Robertis
and Kuroda, 2004; Delaune et al., 2005; Furthauer et al., 2004; Stern,
2002). Inhibition of FGF expression by BMPs can regulate the
establishment of regional domains, for example in the forebrain, in
which this underlies reciprocal expression of FGF8 and BMP4 in
distinct domains (Anderson et al., 2002; Ohkubo et al., 2002;
Shimogori et al., 2004). Furthermore, the expression of the BMP
inhibitor noggin in the telencephalon enables the upregulation of
FGF8 and is itself negatively regulated by BMPs (Anderson et al., 2002;
Ohkubo et al., 2002; Shimogori et al., 2004).
In view of the antagonistic relationships between FGF and BMP
signaling being required for patterning elsewhere in the nervous
system, it is intriguing that there appear to be similarities in the
expression of the BMP inhibitor follistatin (Albano et al., 1994;
Connolly et al., 1995; Graham and Lumsden, 1996) and of FGF3
(Mahmood et al., 1995, 1996) in the chick and mouse embryo
hindbrain. Previous studies have shown that BMP induces apoptosis
of r3/r5 neural crest cells (Graham et al., 1994), and that Noggin
prevents this activity in r4 (Smith and Graham, 2001), but the role of
follistatin in the hindbrain has not been elucidated. We have therefore
addressed the possibility that antagonism between BMP and FGF
contributes to the segmental regulation of gene expression in the
hindbrain. In this paper we report that FGF3 expression in speciﬁc
rhombomeres requires the segmental inhibition of BMP activity by
follistatin and that this interaction regulates segmental gene
expression in the hindbrain.
Materials and methods
Embryos
Fertile Loman chick eggs were incubated at 38 °C until embryos
reached the desired somite-stage (ss). Before performing experimen-
tal procedures, eggs were windowed and embryos were visualised by
injecting black ink below the blastodisc. Following manipulations,
embryos were incubated to the required stage, ﬁxed in 4% parafor-
maldehyde, dehydrated in 100% methanol, and stored at −20 °C.
In ovo electroporation
FITC-conjugated follistatin or control antisense morpholino (MO)
oligonucleotides were diluted in PBS to a working concentration of
2 mM. Two sets of follistatin-MO were designed according to the
manufacturer's criteria (GeneTools, OR USA), one targeted to prevent
translation of the protein (follistatin-MO) and the other to create a
misspliced protein (Ex2 Int2-MO) by blocking the splice region
between exon 2 and intron 2. The sequences used are as follows:
follistatin-MO: 5′-TAACATCCTCAGCTTAGCAGGGAGT-3′, Ex2 Int2-MO:
5′-TCCACATTCTCACATGTTTCTTTGC-3′, control-MO: 5′-CCTCTTACCT-
CAGTTACAATTTATA-3′. Full-length mouse BMP4 cDNA was inserted
upstream of an internal ribosomal entry site (IRES) and nuclear
localization sequence-tagged GFP in pCAGGS expression vector
plasmid (a gift from J. Briscoe). pCAGGS-BMP-IRES-GFP and control
pCAGGS-IRES-GFP were diluted in 10 mM Tris pH 8.5 to a workingconcentration of 100 ng/μl or 2 μg/μl, respectively. Full-length Xenopus
follistatin cDNA in CMV expression vector (a gift from N. Itasaki)
was diluted in 10 mM Tris pH 8.5 to a working concentration of
2 μg/μl.
MO-oligonucleotides or cDNAs were injected into the hindbrain
lumen of embryos by using a pulled glass capillary. Following
injection, electrodes were placed either above and below the embryo
to obtain bilateral hindbrain transfection or at both the left and right
sides of the hindbrain to obtain unilateral and dorsal transfection.
Electroporation was performed using a BTX 3000 electroporator with
four 45-millisecond pulses of 16–18 V and pulse intervals of 300 ms
(Itasaki et al., 1999).
Bead implantation
Heparin acrylic beadswere soaked at 4 °C for 2 h in FGF3 (1mg/ml),
follistatin (1 mg/ml), or BMP4 (10 ng/μl) (R&D systems, MN USA) all
diluted in PBS-0.3% BSA, or in PBS-0.3% BSA solution as a control. AGX-
100 beadswere soaked at room temperature for 2 h in SU5402 (200 μM,
Calbiochem, CAUSA) or DMSO. Beads were implanted in the hindbrain
lumenof 4–8ss embryos,whichwere then incubated for further 3–20h.
Beads were removed before in situ hybridisation procedure.
Whole-mount in situ hybridization and immunohistochemistry
Whole-mount in situ hybridization was performed as described
(Sela-Donenfeld and Kalcheim,1999), using probes for chick FGF3 (EST
clone 812g6, MRC Geneservice), follistatin (Connolly et al., 1995) BMP5
(EST clone 248c4, MRC Geneservice), BMP4 (Sela-Donenfeld and
Kalcheim, 1999), Pax6, Nkx6.2 (a gift from J. Briscoe), Krox20 (a gift
from P. Charnay) (Marin and Charnay, 2000), Hoxb1 (a gift from R.
Krumlauf) and Msx1 (a gift from A. Graham). For double in situ
hybridization, probes were either labelledwith digoxigenin (DIG)-UTP
or ﬂuorescein-UTP and detected using alkaline phosphatase-coupled
antibody (1:2000, Roche, Basel Switzerland). First, the DIG labelled
probe was detected using NBT/BCIP as substrate (Roche, Basel
Switzerland), after which embryos were treated with 100% methanol
to inactivate alkaline phosphatase. Following the second antibody
addition, embryos were stained with Fast Red (Roche, Basel
Switzerland) to reveal the ﬂuorescein-labelled probe.
Whole-mount immunohistochemical localisation of proteins was
carried out following some in situ hybridizations. Brieﬂy, embryos
were incubated in PBS with 0.1% Tween20, 5% goat serum for 2 h and
then incubated with the following antibodies overnight: rabbit anti-
GFP (1:400, Molecular Probes, OR USA), sheep anti-ﬂuorescein to
detect FITC-conjugated MO-oligonucleotides (1:2000, Roche, Basel
Switzerland)., rabbit anti-EphA4 (1:250) (Irving et al., 1996), and
mouse anti-chondroitin sulphate proteoglycan (CSPG, 1:50, Sigma,
MO USA). Following PBS washes, the following secondary antibodies
were added: anti-rabbit or anti-mouse Alexa 488, anti-rabbit Alexa
594 (all 1:400, Molecular Probes, OR USA), anti-rabbit-HRP (1:250,
Sigma, MO USA). Depending on the reagents used, the embryos were
then stained with DAB (diaminobenzidine tetrahydrochloride, Sigma,
MO USA) to reveal HRP activity, with Fast Red (Roche, Basel
Switzerland) to reveal FITC-MO expressing cells, or visualised for
ﬂuorescent labelling.
Cell death detection assay
Cell death in whole mount embryos was detected by terminal
transferase UTP nicked end labelling (TUNEL) according to a modiﬁed
manufacturer's protocol (Roche, Basel Switzerland). Brieﬂy, embryos
were ﬁxed in 4% PFA for 1 h at room temperature, washed in PBS,
blocked in 3% H2O2 (in methanol) for 1 h at room temperature, and
again washed in PBS. Embryos were permeabilized (0.1% Triton, 0.1%
sodium citrate) on ice for 15 min and washed in PBS. Embryos were
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Basel Switzerland). POD labelled cells were visualized using AEC
substrate system (Lab Vision Corporation, CA USA).
Results
Expression pattern of FGF3, follistatin and BMPs in the developing
chick hindbrain
Based on previous studies, FGF3 and follistatin appear to be
expressed in the chick and mouse hindbrain (Albano et al., 1994;
Connolly et al., 1995; Graham et al., 1994; Graham and Lumsden,1996;
Mahmood et al., 1995, 1996; Oh et al., 1996), but the expression
patterns of these genes have not been directly compared. We
therefore compared in detail the dynamic expression of FGF3 and
follistatin during chick hindbrain development. As early as the 2
somite-stage (ss), FGF3 is expressed in presumptive r4 throughout the
dorsal–ventral (DV) extent of the segment (Supplementary Figs. 1A,
A'). This expression continues in 4ss–8ss embryos with an expansion
into presumptive r5 and r6 (Supplementary Figs. 1B,B',C and A). In
comparison, in 2ss–4ss embryos follistatin mRNAs are expressed
dorsally along the entire length of the neural folds, whereas in
presumptive r4–r6, it is also distributed slightly more ventrally
(Supplementary Figs. 1D–E'). In 6ss embryos follistatin expression is
more evident throughout the DV extent of r4–r6, similar to FGF3, and
its dorsal expression in r3 is no longer apparent (Supplementary Fig.
1F). In 8ss embryos, FGF3 and follistatin continue to be expressed in
r4–r6 (Figs. 1A,G), and dorsal follistatin expression remains in r2, but is
downregulated in the more rostral domains of the hindbrain (Fig. 1G).Fig. 1. Expression of FGF3, follistatin, and BMPs in the chick hindbrain. In situ hybridization wa
BMP5 and (S) FGF3 (blue) and Krox20 (red) at the stages indicated, shown in ﬂat mount prepar
similar pattern, at early stages in rhombomeres and later in hindbrain boundary cells. BMP4 a
indicated, ﬂoor plate (FP) is marked and anterior is at the top.In 12ss embryos, overlapping r4–r6 expression of FGF3 and follistatin
continues and becomes more ventrally restricted, whereas FGF3 is
now present also in r2 (Figs. 1B, H). A double in situ hybridization of
FGF3 and Krox20 (expressed in r3 and r5) at this stage shows the
speciﬁc segmental expression of both genes (Fig. 1S, FGF3 in blue and
Krox20 in red). Subsequently, the expression of FGF3 and follistatin is
progressively downregulated from the rhombomeres while being
upregulated in the inter-rhombomeric boundary cells, while they
remain excluded from the dorsal neuroepithelium (Figs. 1C–F, I–L). At
18ss, both genes are expressed in r2, r4 and r6 and are disappearing
from r5 (Figs. 1C, I), while at 22ss the expression in r2 disappears and
expression in r2/3, r3/4, r4/5 and r5/6 boundary cells is now evident
(Figs. 1D, J). By 27ss, rhombomeric expression of FGF3 and follistatin is
no longer detected in r4, is still present in r6, and their expression in
boundary cells has become more prominent (Figs. 1E, K). In 30–45ss
embryos, FGF3 and follistatin transcripts are conﬁned to the hindbrain
boundary cells and are absent from all rhombomere bodies (Figs. 1F, L
and data not shown). At these stages, follistatin is also expressed in a
DV restricted stripe along the hindbrain that may correlate with the
alar–basal border of the neural tube (our unpublished data).
Since follistatin acts as an inhibitor of several TGFβ family protein
members such as activins and BMP4–7 (Iemura et al., 1998; Liem et al.,
1997; Nakamura et al., 1990; Yamashita et al., 1995), we examined the
expression patterns of these genes in the hindbrain of 2–40ss embryos
and found that they are largely excluded from follistatin and FGF3
domains. In 2ss embryos BMP4 is dorsally restricted in the anterior
nervous system (Supplementary Figs. 1G, G'). In 4ss embryos the
dorsal expression of BMP4 is expanded posteriorly to the anterior part
of the hindbrain (Supplementary Figs. 1H, H') and is further caudallys carried out to detect the expression of (A–F) FGF3, (G–L) follistatin, (M–O) BMP4, (P–R)
ations of the hindbrain. Dynamic segmental expression of FGF3 and follistatin occurs in a
nd BMP5 are expressed in the dorsal hindbrain. Rhombomeres are numbered, probes are
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(Supplementary Fig. 1I). In 8ss and 12ss embryos BMP4 is expressed
along the dorsal AP axis of the hindbrain and is found at slightly higher
levels in r3 and r5 as compared to the adjacent rhombomeres (Figs.
1M, N). At later stages the dorsal expression of BMP4 is evenly
distributed along the entire hindbrain (Fig. 1O). The expression of
BMP5 is reminiscent of that of BMP4 with higher levels of dorsal
expression in r3 and r5, although for BMP5 the r3 expression expands
ventrally in 12ss embryos (Figs. 1P, Q). The segmental differences of
both BMP4 and BMP5mRNA levels in these stages are consistent with
previous studies, where BMPs were shown to control neural crest cell
death in r3, r5 (Farlie et al., 1999; Graham et al., 1994) and locus
coeruleus differentiation in r1 (Vogel-Hopker and Rohrer, 2002),
although we observe dorsal expression of BMP4 and BMP5 also in
even numbered rhombomeres (Figs. 1M, N, P, and Q, and see also Oh
et al., 1996), probably due to differences in the hybridisation
sensitivity. At later stages BMP5 expression is again similar to BMP4
and is evenly distributed along the entire dorsal hindbrain (Fig. 1R).
This dorsal expression is consistent with roles of BMPs in DV
patterning (Hornbruch et al., 2005; Lee and Jessell, 1999; Liem et
al., 1997; Timmer et al., 2002). BMP7 and ActivinA are not expressedFig. 2. Inhibition of follistatin leads to loss of segmental FGF3. (A–H) Expression of FGF3 in the
follistatin-MO (C, D, and F) or Ex2Int2-MO (H) at the indicated stages and further incuba
expression of FGF3, whereas embryos electroporated with follistatin-MO or Ex2Int2 MO sho
electroporated at the indicated stages with control-MO (I,K) or follistatin-MO (J, L) and incu
expression of Nkx6.2 or dorsal expression of Pax7 mRNAs. Probes are indicated, rhombomerin the hindbrain (data not shown, and see also Connolly et al., 1995;
Oh et al., 1996), although BMP7 transcripts are detected in the
adjacent otic vesicle and ectoderm as well as in ventral midline cells
of more anterior regions (Dale et al., 1999; Oh et al., 1996), suggesting
BMP7 to be an additional candidate for follistatin inhibition.
Taken together, these data indicate that in early embryos of 2–4ss,
the restricted AP expression of FGF3 is more prominent than follistatin
in the hindbrain, a stage where BMP is not yet expressed in the caudal
hindbrain region. From 6–40ss, FGF3 and follistatin show a more
similar spatial and temporal segmental expression in the rhombo-
meres and later in boundary cells, an expression which gradually
becomes restricted to the ventral side of the neuroepithelium, distal
from the domain of BMP expression.
FGF3 expression requires follistatin
The expression proﬁles of FGF3 and follistatin raise the possibility
that the segmental expression of FGF3 is dependent upon inhibition of
BMPs by follistatin. To test this, we ﬁrst examined whether loss of
follistatin protein in the hindbrain affects FGF3 expression. FITC-
conjugated morpholino antisense oligonucleotides (MO) directedhindbrain of embryos electroporated with FITC-conjugated control-MO (A, B, E, and G),
ted for 14 h prior to ﬁxation. Embryos electroporated with control-MO show normal
w reduced FGF3 expression. (I–L) Expression of Nkx6.2 (I, J) and Pax7 (K, L) in embryos
bated for 16 h prior to ﬁxation. Follistatin-MO does not alter either the normal ventral
es are numbered and anterior is at the top.
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(follistatin-MO), or a control FITC-conjugated MO (control-MO), were
electroporated into the hindbrain of ∼4ss or ∼10ss embryos and the
expression of FGF3 was analyzed 14 h later. FGF3 expression was
normal in embryos electroporated with control-MO (Figs. 2A, B, and E,
14/14 embryos for each stage), but greatly reduced in the hindbrain
of embryos electroporatedwith follistatin-MO (Figs. 2C, D, and F,16/16
embryos for each stage). To verify our results, we electroporated
embryos with an additional MO to counter follistatin, but in this
instance the MO targeted the splice region between the second exon–
intron junction (Ex2Int2-MO) thereby producing a misspliced protein
(Eisen and Smith, 2008). Embryos were incubated for an additional
14 h. Our results show that, similarly to the previously used MO (Figs.
2C, D, and F), FGF3 expressionwas reduced in the embryos transfected
with the Ex2Int2-MO (Fig. 2H n=9/10) as opposed to the control (Fig.
2G n=0/7). We noticed that in some cases the level of FGF3 expression
was lowered even in domains which do not contain follistatin-MO.
This may be due to more cells expressing follistatin-MO than our
detection system can detect or it may also be possible that follistatin
has a wide diffusion radius and that its concentration is limiting, such
that follistatin knockdown by the MO causes it to be less available also
in areas that are outside of the knockdown domain. To demonstrate
that the effect of the follistatin-MO on the segmental expression of
FGF3 is speciﬁc, we electroporated embryos with follistatin-MO,
incubated for a further 14 h and thereafter analysed the expression of
two non-segmentally expressed genes, one ventral, Nkx6.2, and one
dorsal, Pax7. In both cases the expression pattern of the follistatin-MO
electroporated embryos (Fig. 2J for Nkx6.2 n=6/6 and 2L for Pax7
n=13/16)was not different from that of the control embryos (Fig. 2I for
Nkx6.2 n=5/5 and 2K for Pax7 n=9/9). The lack of effect on both genes
further conﬁrms the speciﬁc AP restricted activity of follistatin.
Moreover, this indicates that although Pax7 is a target of dorsally-Fig. 3. Addition of follistatin causes the upregulation of FGF3. (A–D) Expression of FGF3 in 4ss
and incubated for a further 14 h prior to ﬁxation. Follistatin treated embryos have increased F
dorsal regions as well as in r3 (black arrows). Since follistatin-treated embryos had signiﬁca
stopped much sooner than in other experiments, resulting in a weaker FGF3 staining in co
embryos dorsally electroporated at ∼3ss with a control (E) or follistatin overexpression con
show ectopic expression of FGF3 (black arrows) as compared to control embryos. (G, H) Expre
follistatin-MO (G) or electroporation of follistatin-MO in conjunction with follistatin bead im
given the combined treatment of follistatin and follistatin-MO showa rescue of FGF3 expressi
MO expressing cells detectedwith anti-ﬂuorescein antibody. Probes are indicated, rhombomederived BMPs (Timmer et al., 2002), its homogenous DV distribution
along the hindbrain does not involve segmental inhibitory activity of
follistatin. Together, these results indicate that follistatin is required for
rhombomeric expression of FGF3. To testwhether follistatin is sufﬁcient
for segmental FGF3 expression, we analyzed the effect of ectopic
follistatin on FGF3 expression. Follistatin or PBS/BSA soaked beadswere
implanted into the hindbrain lumen of 4ss embryos and analyzed for
FGF3 expression 14 h later (Figs. 3A–D). Embryos treatedwith follistatin
had signiﬁcantly stronger expression of FGF3 in the hindbrain
compared to PBS/BSA treated embryos (compare Figs. 3A to B–D,
n=18/26 for follistatin, n=18/20 for control). Furthermore, ectopic
expression of FGF3 was evident in some embryos in the ﬂoor plate,
dorsal regions or in r3 (Figs. 3B, C), domains which normally do not
express FGF3 (Figs. 1A–F). These experiments indicate that excess
follistatin increases FGF3 levels in endogenous domains and also
induces FGF3 expression in ectopic hindbrain regions. In an additional
approach, we electroporated embryos with a follistatin overexpression
construct and then analysed its effect on the expression of FGF3.
Similarly to the exogenous addition of follistatin, we noted an ectopic
expression of FGF3, but in this case, in the dorsal domain of the
hindbrain (Fig. 3F), where the construct was electroporated. This
ectopic expressionwas not observed in the control embryos (Fig. 3E). To
verify these results we performed a rescue experiment. We prevented
the expression of endogenous follistatin by electroporation of follista-
tin-MOand then implanted either a control or a follistatin-soaked bead.
Our results show that, as previously seen, FGF3 is reduced in follistatin-
MO electroporated embryos (Fig. 3G n=7/7), but that the expression of
FGF3 is largely re-established in the rescue experiment (Fig. 3H n=5/6).
Taken together, our results indicate that inhibition or application of
follistatin results in loss or overexpression of FGF3, respectively,
suggesting that the segmental expression/activity of follistatin is
necessary for segmental expression of FGF3 in the hindbrain.embryos implanted with control (A) or follistatin (B–D) beads in their hindbrain lumen
GF3 expression levels compared to control embryos and also ectopic FGF3 in ventral and
ntly higher expression of FGF3, staining of the experimental and control embryos was
ntrol embryos in (A) compared to controls in (Figs. 2A, B). (E, F) Expression of FGF3 in
struct (F) and allowed to develop for a further 14 h. Follistatin electroporated embryos
ssion of FGF3 in the hindbrain of embryos treated at ∼3ss with either electroporation of
plantation (H). Embryos were incubated an additional 14 h prior to ﬁxation. Embryos
on relative to embryos treatedwith follistatin-MO alone. The red staining corresponds to
res are numbered, localization of bead implantation is marked and anterior is at the top.
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To further test whether FGF3 expression requires inhibition of BMP
signaling, we overexpressed BMP4 in the hindbrain to override the
inhibition by follistatin. Embryos were electroporated unilaterally and
dorsally with a vector that drives expression of either GFP alone or of
BMP4 and GFP. The BMP4 construct was used at a low concentration of
100 ng/μl to drive BMP4 overexpression without generating excessive
neuroepithelial cell death (Timmer et al., 2002), which we conﬁrmed
by performing a TUNEL assay on ∼15ss embryos after either GFP or
BMP4 electroporation at ∼4ss. Both control embryos (Fig. 4F n=7/7)
and BMP4 electroporated embryos (Fig. 4G n=7/8) showed similar
amount of cell death. Rhombomeric FGF3 expression was strongly
suppressed in embryos 14 h after electroporation of BMP4 vector at
∼4ss or ∼10ss (Figs. 4A–E, n=23/25 for BMP4, 0/15 for control). The
amount of FGF3 inhibition by BMP4 was dependent on the over-
expression level indirectly detected by anti-GFP staining: limited
transfection of BMP4 correlated with unilateral effects of FGF3 while
more extensive overexpression resulted in bilateral suppression of
FGF3 (Fig. 4, compare transfected cells in B versus C).
Misexpression of BMPs in ventral regions of the neural tube was
shown to broaden the expression of dorsal genes and to downregulate
ventrally-expressed genes in the CNS (Liem et al., 1997; Timmer et al.,
2005, 2002). Based on the results of previous studies (Hornbruch et al.,
2005; Timmer et al., 2005), the dorsal and lower overexpression levelFig. 4. Overexpression of BMP4 inhibits FGF3 expression. (A–E) Expression of FGF3 in the
pCAGGS-IRES-GFP (A, D) or BMP4-IRES-GFP (B, C, and E) plasmids and allowed to develop for
was detected with HRP-conjugated antibody (brown stain). FGF3 expression occurs at norm
electroporated with BMP4 expression vector. The effect of BMP4 on FGF3 inhibition is stronge
either control pCAGGS-IRES-GFP (F) or BMP4-IRES-GFP (G), allowed to develop for 20 h and
control and BMP4 electroporated embryos. (H–M) Expression of Nkx6.2 (H–K; dark blue in
∼10ss with control GFP (H, J, and L; insert in J shows electroporated area) or BMP4 (I, K, a
Overexpression of BMP4 does not alter the normal ventral expression of Nkx6.2 and Pax6
unilaterally electroporated at ∼3ss with control GFP (N) or BMP4 (O) and incubated for
electroporated embryos. Note that the ventral expression ofMsx1 is slightly more pronounced
FGF3 expression in embryos implanted at ∼8ss with PBS/BSA (P, R, and T) or BMP4 (Q, S, and U
at normal levels in control embryos (P, R, and T) and 3 h after addition of BMP4 (Q), but is lo
numbered, otic vesicle (OV) is marked, probes are indicated, beads position is marked andof BMP4 used in our experiments is predicted not to cause such
dorsalisation. Since dorsalisation would lead to a loss of ventral FGF3
expression, it was therefore important to ascertain whether or not
dorsalisation occurs in our experiments. ∼10ss embryos were
electroporated unilaterally in the dorsal region of the hindbrain
with BMP4 or control plasmids (at the same concentrations as in Figs.
4A–G), and the expression of two ventral genes, Nkx6.2 and Pax6, was
analysed 24 h later. We found that expression of both Nkx6.2 (n=12/
15) and Pax6 (n=5/5) in BMP4-expressing embryos was either
indistinguishable from control embryos (n=6/6 for Nkx6.2 and for
Pax6) or only slightly reduced (compare Figs. 4I, M to Figs. 4H, L).
Furthermore, double in situ hybridization for FGF3 and Nkx6.2 was
carried out in other BMP4-electroporated embryos and revealed that
within the same embryos, overexpression of BMP4 is not affecting
Nkx6.2 expression, (compare dark blue staining in Fig. 4K, n=6/7
with control in Fig. 4J, n=4/4) whereas FGF3 expression was down-
regulated (compare red staining in Fig. 4K, n=6/7 with control in Fig.
4J, n=0/4). In addition, we examined the location of BMP4 activity by
analysing the expression of Msx1, a downstream target gene of BMP
signaling. 4ss embryos were electroporated with either control GFP or
BMP4 and incubated 20 h prior to ﬁxation. BMP4 electroporated
embryos showed a slightly strongerMsx1 expression level as well as a
unilateral ventral expansion (Fig. 4O n=14/16) compared to the
control embryos (Fig. 4N n=1/14). However, Msx1 medialisation did
not extend to regions where FGF3, Pax6 or Nkx6.2 are expressed,hindbrain of embryos unilaterally electroporated at the indicated stages with control
14 h (electroporated side marked by an asterisk). GFP expression in electroporated cells
al levels in control electroporated embryos and is absent or at low levels in embryos
r with higher levels of BMP4 overexpression. (F, G) embryos electroporated at ∼3ss with
thereafter analysed for cell death revealed by TUNEL assay. Cell death is similar in both
J, K), FGF3 (J, K; red staining) and Pax6 (L, M) in embryos unilaterally electroporated at
nd M; insert in K shows electroporated area) and incubated for 24 h prior to ﬁxation.
mRNAs, whereas FGF3 expression is inhibited. (N, O) Expression of Msx1 in embryos
20 h prior to ﬁxation. Msx1 expression appears stronger and more ventral in BMP4
on the electroporated side (comparewidth of arrows on the electroporated side). (P–U)
) soaked beads and allowed to develop for 3, 6 and 15 h, as indicated. FGF3 expression is
wer in BMP4-treated embryos after 6 h (S) and absent after 15 h (U). Rhombomeres are
anterior is at the top.
Fig. 5. FGF3 maintains its own expression. (A–F) Embryos implanted at the indicated
stages with beads soaked in DMSO (A, C, and E) or SU5402 (B, D, and F), incubated for
16–20 h, ﬁxed and stained for FGF3 (A–D) and follistatin (E, F). FGF3 is absent in SU5402
treated embryos (B, D) compared to control (A, C) while follistatin expression is similar
in both SU5402 treated (E) and control (F) embryos. (G, H) FGF3 expression in the
hindbrain of embryos implanted at the indicated stages with PBS/BSA (G) or FGF3 (H)
beads and incubated for 20 h prior to ﬁxation. FGF3 treated embryos (H) have higher
levels of FGF3 expression as compared to control embryos (G). Rhombomeres are
numbered, probes and bead positions are indicated and anterior is at the top.
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by BMP4 in our experimental conditions is due to general dorsalisa-
tion of the hindbrain.
To determine how rapidly BMP4 downregulates FGF3 expression,
we examined the time course of the effect by implanting BMP4-
soaked beads into the hindbrain of 8ss embryos. After 3 h of
treatment, control (n=6/8) and BMP4-treated embryos (n=5/7)
showed similar FGF3 expression (Figs. 4P, Q although in a few
BMP4-treated embryos a slight reduction was detected (n=2/8, data
not shown). 6 h after BMP addition, the expression of FGF3 was
signiﬁcantly downregulated in the hindbrain (n=6/8), in contrast to
control embryos (n=0/6) (Figs. 4R, S). This downregulation was
enhanced in embryos receiving BMP4 beads for 15 h (n=8/10 for
BMP4, n=0/6 for control) (Figs. 4T, U).
FGF signaling maintains FGF3 expression in the hindbrain
In a number of embryonic tissues FGFs maintain their own
expression in a positive feedback loop (Agarwal et al., 2003; Canning
et al., 2007; Mandler and Neubuser, 2004; Sekine et al., 1999; Trokovic
et al., 2003; Xu et al., 1999b). We therefore addressed whether such
autoregulation may contribute to FGF3 expression in the hindbrain.
Beads soaked in SU5402 (a pharmacological inhibitor of FGF signaling)
or DMSO as a control, were implanted into the hindbrain lumen of
∼4ss or∼12ss embryos, whichwere ﬁxed 16 or 20 h later, respectively.
SU5402 treatment prevented FGF3 expression in embryos at both
stages (Figs. 5B, D; n=7/8 for 4ss embryos, n=12/15 for 12ss embryos).
In contrast, embryos receiving DMSO-beads expressed FGF3 in the
normal pattern in r4–6 (Figs. 5A; n=8/8) and in r6 and boundary cells
(Fig. 5C; n=15/15,). Moreover, similarly treated embryos showed no
effect on follistatin expression in the hindbrain (Figs. 5E, F), suggesting
that FGF signalling does not positively regulate follistatin expression,
as well as indicating that FGF3 downregulation in SU5402 treatment is
not due to toxicity. This result indicates that general blocking of FGF
receptors prevents FGF3 expression. To further examinewhether FGF3
autoregulates its expression, ∼12ss embryos were treated with FGF3
or PBS/BSA soaked beads and ﬁxed 20 h later. FGF3 treated embryos
had signiﬁcantly higher expression levels of FGF3 (n=8/11) compared
to control embryos (n=0/10) (Figs. 5G, H). The high levels of FGF3
expression were evident in both the boundary regions and in r4/r6,
whereas in control embryos at this stage FGF3 has been down-
regulated from rhombomeres and conﬁned to rhombomere bound-
aries. These data indicate that FGF3 expression is regulated by a
positive feedback loop. Thus, we suggest that a combination of FGF
autoregulation together with the inhibition of BMP activity by
follistatin are involved in FGF3 expression in speciﬁc hindbrain
domains.
Segmental expression of Krox20 is obstructed by the inhibition of
follistatin activity
The segmentally-expressed transcription factor Krox20 regulates
the formation and AP speciﬁcation of odd-numbered rhombomeres
(Frohman et al., 1993; Giudicelli et al., 2003; Lumsden and Krumlauf,
1996; Manzanares et al., 1999; Moens et al., 1998; Schneider-
Maunoury et al., 1997; Seitanidou et al., 1997; Voiculescu et al.,
2001). Based on evidence that the expression of this gene requires FGF
signaling (Aragon et al., 2005; Marin and Charnay, 2000; Maves et al.,
2002; Walshe et al., 2002; Wiellette and Sive, 2003), we analysed
whether it is affected by disruption of the FGF3–follistatin–BMP
network.
First, we conﬁrmed that, as described previously (Marin and
Charnay, 2000; Maves et al., 2002; Walshe et al., 2002, Aragon, 2005),
Krox20 expression requires FGF signaling, since implantation of
SU5402 beads into the hindbrain of ∼4ss embryos led to a loss of
Krox20 expression in r3 and r5 20 h later (Fig. 6E, n=13/17) in contrastto control embryos where Krox20 expression remained intact (Fig. 6A,
n=10/10). We next analyzed whether the disruption of endogenous
follistatin protein expression affects Krox20 expression. ∼4ss embryos
were electroporated with control or follistatin-MOs and ﬁxed 20 h
later. Embryos electroporated with control-MO had normal Krox20
expression in r3 and r5, with no differences between the electro-
porated side and the contra-lateral side (Fig. 6B n=12/12). Notably,
MO-labelled cells were commonly found within Krox20 domains,
without affecting its expression. In contrast, in follistatin-MO
electroporated embryos, Krox20 expression was reduced to very low
levels or eliminated (Figs. 6F, G n=9/12). Importantly, when electro-
poration of follistatin-MO was restricted to the dorsal-most region of
the hindbrain, where endogenous follistatin is not expressed (Fig. 1),
Krox20 expression was not disrupted (Fig. 6C n=4/4), as compared
to the ventrally-electroporated embryos (Figs. 6F, G), further conﬁrm-
ing the speciﬁcity of follistatin-MO effect on Krox20. To verify our
results we preformed a rescue experiment on the expression of
Krox20. We electroporated ∼4ss embryos with follistatin-MO and
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conjunction with follistatin-MO electroporation. Our results show
that, as previously shown, Krox20 is reduced in follistatin-MO
electroporated embryos (Fig. 6D n=7/7), but that the expression of
Krox20 is recuperated in the rescue experiment (Fig. 6H n=5/6). The
effect of follistatin-MO on Krox20 expression was long-range as
Krox20 was suppressed also in the contra-lateral side that expresses
less MO (Figs. 6E, F). This result may indicate that more cells express
follistatin-MO and induce Krox20 downregulation, than the cells
stained by our detection system. Alternatively, it is possible that the
non-cell-autonomous effect of follistatin-MO corresponds to the
release of hindbrain BMPs from inhibition by follistatin, which in
turn downregulate FGF3 expression.
To further test this possibility, ∼8ss embryos were unilaterally
electroporated with BMP4-GFP expression vector and analyzed 20 h
later. While in control GFP electroporations, Krox20 expression
occurred in normal r3/r5 domains (Fig. 7A, n=10/10), it was
substantially or totally inhibited in BMP4-transfected embryos (Figs.
7B, C, n=15/17). Similar to our previous experiments, the effect of
BMP4 was non-cell-autonomous and dependent upon the extent of
electroporation: lower levels of Krox20 expression and bilateral
downregulation correlated with a higher amount of BMP4/GFP-
expressing cells (compare green-labelled cells in Fig. 7B' with C').
Together, these and the previous results show that blockage of FGF
signaling, knockdown of follistatin, or overexpression of BMPs, all
suppress Krox20 expression, consistent with the effect of the same
manipulations on FGF3 expression.
EphA4 is a direct target of Krox20 transcriptional activity (Theil et
al., 1998) that interacts with ephrin ligands to restrict cells from
crossing between rhombomeres (Xu et al., 1995, 1999a), and enables
the formation of inter-rhombomeric boundaries (Cooke et al., 2005;
Xu et al., 1995). We therefore analyzed whether the expression of
EphA4 protein and the formation of boundary cells are also affected by
BMP4 overexpression. We found that embryos overexpressing BMP4Fig. 6. Inhibition of follistatin reduces segmental Krox20 expression. (A–H) Expression of Krox
in the hindbrain lumenwith beads soaked in DMSO (A) or SU5402 (E). Krox20 expression is re
(B) or follistatin-MO (C,F,G). Krox20 expression is inhibited in follistatin-MO transfected emb
(D, H) Embryos treated with either electroporation of follistatin-MO (D) or electroporation
combined treatment of FGF3 and follistatin-MO show a rescue of Krox20 expression relativ
expressing cells labelled with anti-ﬂuorescein antibody. Rhombomeres are numbered and ashowed decreased EphA4 expression on the electroporated side of the
hindbrain (Fig. 7G, n=7/9), in contrast to control embryos (Fig. 7F,
n=0/10). To analyse boundary cell formation, embryos ectopically
expressing BMP4 were incubated to later stages when Chondroitin
Sulphate Proteoglycan (CSPG) normally accumulates in chick hind-
brain boundaries (Heyman et al., 1995). CSPG staining in hindbrain
boundaries is disrupted in BMP-transfected embryos (Fig. 7I; n=5/5).
In contrast, control embryos displayed normal rhombomere bound-
aries marked by CSPG (Fig. 7H, n=5/5).
Previous works have suggested that neither the expression of
Hoxb1 in r4 requires FGF signaling within the hindbrain (Bel-Vialar et
al., 2002;Marin andCharnay, 2000;Maves et al., 2002) nor is it affected
inKrox20nullmice (Schneider-Maunoury et al.,1993).While follistatin
addition or inhibition up- or downregulates FGF3 and Krox20
expression, respectively, (Figs. 2, 3, and 6) we anticipated that
follistatin activity would not alter Hoxb1 expression. We implanted
4ss embryos with either PBS- or follistatin-soaked beads and analysed
Hoxb1. Our results show that, as expected, both, control and follistatin
treated embryos display a similar expression levels of Hoxb1
(Supplementary Fig. 2). This result indicates that Hoxb1 is not affected
by follistatin activity, which decreases BMP signaling and leads to an
increase in FGF3 levels (Figs. 2, 3). Moreover, this suggests that the
increase in FGF3 levels, observed by the addition of follistatin (Fig. 3), is
not likely to bemediated byHoxb1. Surprisingly, the opposite approach
of BMP4 overexpression, which suppresses FGF3 and Krox20 (Figs. 4, 7)
caused a decrease in Hoxb1 expression in r4 and in the caudal
hindbrain, (Fig. 7E; blue signal Hoxb1; red signal Krox20; n=6/6), as
compared to control embryos (Fig. 7D, n=0/8). Interestingly, these
embryos also showed Hoxb1 upregulation in the ﬂoor plate of the
posterior rhombomeres (Fig. 7E and data not shown). This unexpected
effect of excess BMP on Hoxb1 may suggest that excessive BMP alters
the expression of other factors that regulate Hoxb1 gene expression in
the hindbrain, not mediated by follistatin, as further elaborated in the
discussion.20 in embryos manipulated at ∼4ss and ﬁxed 20 h later. (A, E) Embryos were implanted
duced upon SU5402 treatment. (B, C, F, and G) Embryos electroporatedwith control-MO
ryos (F, G), but not in either control-MO (B) or dorsally electroporated follistatin-MO (C).
of follistatin-MO in conjunction with FGF3 bead implantation (H). Embryos given the
e to embryos treated with follistatin-MO alone. The red staining corresponds to MO-
nterior is at the top.
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In this study, we have investigated regulatory interactions between
follistatin, BMPs and FGF3 in early chick hindbrain. We found that
follistatin is co-expressed with FGF3 in a dynamic pattern in hindbrain
segments and subsequently in hindbrain boundaries. The results of
gain- and loss-of-function experiments revealed that the local
inhibition of BMP activity by follistatin is required for the expression
of FGF3. In addition, FGF3 expression requires FGFR activation,
suggesting that it acts in an autoregulatory loop. The segmental
inhibition of BMP activity by follistatin is also required for the
segmental expression of Krox20, which in turn regulates Eph receptors
that underlie boundary formation in the hindbrain. These ﬁndings
reveal a novel role for follistatin in establishing FGF3 expression and
segmental patterning in the chick hindbrain, and indicate that an
antagonistic interaction between BMP and FGF in rhombomeres is
involved in regional speciﬁcation in the hindbrain.
Mechanisms that regulate FGF expression
A number of studies have found that BMPs inhibit the expression of
speciﬁc FGFs in other regions of the developing nervous system. At
early stages of the anterior chick and mouse forebrain, BMP4 and FGF8
are expressed in reciprocal domains, and increase or inhibition of
BMP4 signaling represses or enhances FGF8 expression, respectively
(Anderson et al., 2002; Ohkubo et al., 2002). Moreover, increased BMP
signaling also represses Shh in the prosencephalon, and Shh mutant
mice have enhanced BMP signaling and loss of FGF8 expression
(Anderson et al., 2002; Ohkubo et al., 2002). This antagonistic cross-
regulation of BMP4, FGF8 and Shh signaling centres regulate regional
speciﬁcation in the telencephalon and optic vesicles. Similarly, at later
developmental stages in the cerebral cortex of mouse embryos, BMPs
arising from the cortical hemisphere constrain FGF8 expression to the
anterior telencephalon (Shimogori et al., 2004). This cross-inhibition
is critical for Wnt1 expression and signaling (Gunhaga et al., 2003;
Shimogori et al., 2004), and is integrated by the transcription factorFig. 7. Overexpression of BMP impairs the expression of segmental genes. (A–E) Embryos un
plasmids and incubated for 20 h (electroporated side is marked by an asterisk). Krox20 exp
Distribution of GFP-expressing cells which corresponds to the electroporated side are shown
decreased expression Hoxb1 (E, blue signal; Krox20 is red signal) compared to controls (D). (F
ﬁxed 40 h later. Immunocytochemistry was carried out to detect EphA4 (F, G) or chondro
decreased expression of EphA4 in r3 and r5 (G), and of CSPG in hindbrain boundaries (I), co
antibodies are indicated at the top of each row and anterior is at the top.Emx2 in the early cortical primordium. Emx2 mutant mice have an
expansion of Noggin and FGF8 expression, together with reduction of
Wnt and BMP signaling, leading to severe hippocampal defects
(Fukuchi-Shimogori and Grove, 2003). These ﬁndings suggest that
Emx2 regulates Noggin and BMP expression and activity, which in
turn controls FGF8 and Wnt1 signaling. It is therefore interesting that
the Wnt antagonist molecule, SFRP2, is co-expressed with FGF3 and
follistatin in even numbered rhombomeres in the chick hindbrain
(Ellies et al., 2000), while Wnt1 is localized dorsally, similar to BMPs
(Hollyday et al., 1995). Further investigation will be required to
elucidatewhether there is a regulatory relationship between FGF, BMP
and Wnt expression in the hindbrain.
Our ﬁndings show that FGF3 expression in the hindbrain is
autoregulated by FGF signaling, as SU5402 or FGF3 application
represses or enhances FGF3 expression, respectively. This data is at
apparent variance with Aragon et al., (2005), where SU5402 was
reported not to downregulate FGF3 expression. However, careful
examination of their study shows that some loss of FGF3 expression
may be seen upon FGFR inhibition, albeit to a lower extent than in our
study. Moreover, in both studies Krox20 expression, which has been
suggested to be regulated by FGF signaling in chick and in zebraﬁsh
(Marin and Charnay, 2000; Maves et al., 2002; Walshe et al., 2002;
Wiellette and Sive, 2003), is suppressed by SU5402 treatment. The
discrepancy between these studies regarding the FGF3 autoregulation
activity may be explained by the differences in the concentration or
time exposure to the inhibitor, and in the ex-vivo conditions used in
Aragon et al., (2005) as compared to the in-vivo approach used here.
Positive feedback on FGF expression has been also found in several
other tissues. For example, In the midbrain–hindbrain boundary FGF8
autoregulates its expression (Canning et al., 2007; Trokovic et al.,
2003) and this positive feedback loop is essential for the formation
and differentiation of the cerebellum and anterior hindbrain (Canning
et al., 2007; Foucher et al., 2006; Jukkola et al., 2006; Mason et al.,
2000; Roy and Sagerstrom, 2004; Trokovic et al., 2003). Moreover,
during toothmorphogenesis, FGF3 expression and activity is regulated
by FGF signaling (Jackman et al., 2004; Kettunen et al., 2000).ilaterally electroporated at ∼8ss with control GFP (A, D) or BMP4-IRES-GFP (B, C, and E)
ression is decreased in BMP4 electroporated embryos (B, C) compared to controls (A).
in panels A'–C' and are respective to images A–C. Similarly, BMP4 overexpression leads to
–I) embryos were electroporated at ∼8ss with control (F, H) or BMP4 (G, I) plasmids and
itin-sulphate proteoglycan (CSPG) (H, I) proteins. BMP4 electroporated embryos have
mpared to control transfected embryos (F,H). Rhombomeres are numbered, probes and
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expression in the presence of low, but not high, BMP signaling
(Mandler and Neubuser, 2004). We propose that an analogous
situation occurs in the hindbrain, in which an autoregulatory loop
maintains FGF3 expression in the presence of follistatin, but this loop
is not established when FGF3 expression is inhibited by high BMP
activity.
Previous studies have found that several transcription factors are
involved in the regulation of hindbrain FGF3 expression. Ectopic
expression of the homeobox-containing gene vHnf1 resulted in the
upregulation of chick FGF3 mRNA in both cell-autonomous and non-
cell-autonomous (Aragon et al., 2005). Also, FGF3 expression in the
posterior mouse hindbrain was disrupted in Kreisler as well as in
Hoxa1 mutants, (Carpenter et al., 1993; Frohman et al., 1993; Mark
et al., 1993; McKay et al., 1996; Pasqualetti et al., 2001). The disruption
of FGF3 expression in Hoxa1−/− embryos was partially rescued by
addition of retinoic acid (RA), indicating that RA signaling is involved
in the regulation of FGF3 expression in the posterior hindbrain
(Pasqualetti et al., 2001). Other data from zebraﬁsh embryos shows
that Pbx and Meis homeodomain proteins interact with Hox group 1
genes to induce FGF signals in r4 (Waskiewicz et al., 2002). However,
our results shows that Hoxb1 does not mediate FGF3 expression by
follistatin. Further research will be required to determine whether
and how follistatin activity to regulate FGF3 expression is combined
with that of vHnf1, MafB/Kreisler and Hox and Pbx proteins, as well as
with RA signaling pathways.
An important question raised by our results is whether BMP
signaling directly downregulates FGF3 expression, or acts via an
intermediary factor. Our ﬁnding that FGF3 expression is down-
regulated within 6 h of implanting BMP4 beads is consistent with
either possibility. However, the medial expansion of the BMP readout
gene Msx1, observed in the BMP4 misexpressing embryos, does not
overlap with the expression regions of FGF3, which are more ventral.
This result favours the possibility that the segmental inhibition of
FGF3, observed by overexpression of BMP4, is mediated through
unknown factor(s) downstream of BMPs. Alternatively, several studies
regarding the promoter/enhancer analysis of FGF3 gene have
identiﬁed positive and negative regulatory regions, some of which
affect the expression of FGF3 in the hindbrain (Murakami et al., 1993,
2001, 2004, 1999; Powles et al., 2004). Important clues regarding BMP
repression mechanism on FGF3 will come from either detailed
mapping of these and other regulatory regions of the FGF3 gene as
well as from uncovering downstream molecule/s responsible for
mediating the BMP signal.
Potential function of FGF3 in the hindbrain
Previous studies have implicated FGF signaling in hindbrain
segmentation. The expression of FGF3 and FGF8 in r4 in the zebraﬁsh
hindbrain is essential for Krox20 expression in r5 and Kreisler/Val
expression in r5/r6, which are required for segmentation of the
posterior hindbrain (Maves et al., 2002; Walshe et al., 2002; Wiellette
and Sive, 2003). In contrast to zebraﬁsh, FGF8 is not expressed in the
chick or mouse hindbrain, while FGF3 has dynamic expression in r2,
r4–r6 and hindbrain boundaries (Mahmood et al., 1995, 1996; McKay
et al., 1994; Powles et al., 2004; Wilkinson et al., 1988). Although a
direct role for FGF3 in patterning the chick hindbrain was not shown
yet, different FGFRs and several cytoplasmic FGF signaling compo-
nents (such as ERK1/2 andMkp3) have been shown to be expressed in
the hindbrain of early chick embryos (Lunn et al., 2007; Walshe and
Mason, 2000), suggesting a role for FGF signaling in the hindbrain.
Moreover, FGFR activation was demonstrated to be essential for
Krox20 and Kr/MafB expression in the chick (Aragon et al., 2005;Marin
and Charnay, 2000). However, inactivation of the FGF3 gene in the
mouse has revealed roles in inner ear induction (Alvarez et al., 2003;
Mansour et al., 1993) but did not affect hindbrain segmentation(Wright and Mansour, 2003). Although it is currently unclear whether
FGF3 also has a role within the mammalian hindbrain, perhaps acting
redundantly with other FGFs, the expression pattern of FGF3 does not
seem consistent with a role only in inner ear induction, but also in
hindbrain organization, as shown in the zebraﬁsh (Maves et al., 2002;
Walshe et al., 2002; Wiellette and Sive, 2003).
Our ﬁndings that knockdown of follistatin or overexpression of
BMP leads to loss of FGF3 and Krox20 expression, as inhibition of FGFR
does, is most simply interpreted as the inhibition of BMPs in speciﬁc
hindbrain segments being essential for upregulation of FGFs that may
include FGF3. Intriguingly, in chick the expression of Krox20 in r3, but
not in r5, is dependent upon neighbour interaction of r4 (Graham and
Lumsden, 1996), and Krox20 inhibits follistatin expression in r3
(Giudicelli et al., 2001; Seitanidou et al., 1997). This suggests a
model in which follistatin in r4 enables expression of FGFs that
promote Krox20 expression and consequently downregulate follistatin
in r3. Similarly, follistatin may be required for FGF signals that are
essential for r5 development. However, unlike the situation in r3,
follistatin and FGF3 are expressed at early stages in r5, and follistatin
subsequent downregulation from this segment is not dependent on
Krox20 expression (Seitanidou et al., 1997).
Our results show that excess BMP4 inhibits EphA4 protein
expression in r3 and r5. As EphA4 transcription is regulated by Krox20
(Theil et al., 1998), the simplest explanation is that loss of FGF3 due to
BMP overexpression results in a lack of Krox20 expression, and
consequently a failure to upregulate EphA4. The lack of boundary cells
in these embryos is in agreementwith studies in zebraﬁsh showing that
EphA4 signaling is required for boundary cell formation (Cooke et al.,
2005; Xu et al., 1995).
Unexpectedly, we found that the expression of Hoxb1 in r4 is
reduced upon overexpression of BMP4. In contrast, addition of
follistatin did not increase the levels of Hoxb1, which would have
been expected were it regulated by BMP-inhibition mediated by
follistatin. These results may indicate that ectopic BMP down-
regulates signals other than FGF3 that are required for Hoxb1
expression, whereas decreased BMP levels (upon follistatin bead
application) does not disrupt Hoxb1 as the required signals are still
present. Other studies have shown that either repression of FGF
signaling (Marin and Charnay, 2000; Maves et al., 2002) or of
Krox20 (Schneider-Maunoury et al., 1993) does not alter Hoxb1
expression. Thus, the lack of effect on Hoxb1 by follistatin bead
suggests that follistatin activity which regulates FGF3, which in turn
regulates Krox20, is not involving Hoxb1. However, another study in
zebraﬁsh has found that knockdown of FGFs leads to loss of both
Krox20 and Hoxb1 (Walshe et al., 2002), Further studies are required
to elucidate how the cross talk between FGF-BMP-follistatin regulate
Hox genes.
Roles of BMPs in dorsoventral and segmental patterning
It is well established that the dorsally-expressed TGFβ family
members, including BMPs, have crucial roles in the dorsoventral (DV)
speciﬁcation of cell types in the neural tube (Chizhikov and Millen,
2005; Lee and Jessell, 1999; Timmer et al., 2002). An important
question raised from our studies is how the role of follistatin in
segmental patterning does not interferewith the involvement of BMPs
in DV speciﬁcation.
One possibility is that different TGFβ family members are involved
in segmental versus DV patterning and that follistatin speciﬁcally
inhibits only the former members. Smith and Graham (2001) have
suggested that some BMPs are required for hindbrain neural crest
formation, while others induce segmental neural crest apoptosis at r3
and r5 (Smith and Graham, 2001). The TGFβ familymember Vg1 is one
candidate that was shown to be restricted to odd-numbered segments
in the chick hindbrain (Shah et al., 1997), suggesting that follistatin
may antagonise its activity in a speciﬁc AP manner. GDF7, which is
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is another candidate that has been shown to specify dorsal fates in the
spinal cord without being inhibited by follistatin (Lee et al., 1998). Our
results that follistatin-MO does not alter DV markers further argues
against a role of follistatin to affect DV patterning in the hindbrain.
However, the ﬁnding that overexpression of follistatin in the chick
spinal cord causes a dorsal to ventral switch in cell identity (Liem et al.,
2000), suggests that BMPs inhibited by follistatin also contributes to
DV speciﬁcation in the trunk.
Another possible explanation is that follistatin and BMPs have
stage-speciﬁc roles in the hindbrain, initially in segmental patterning
and later in DV speciﬁcation. Indeed, BMPs are implicated in the
speciﬁcation of ﬁrst-order relay sensory neurons that develop in
the hindbrain from around 28ss (Hornbruch et al., 2005), after the
downregulation of the segmental expression of follistatin. Notably, at
late stages follistatin becomes expressed in a longitudinal column in
r2–r7 that may correspond to the alar–basal plate border and could
antagonise dorsally-expressed BMPs. In agreement with this possibi-
lity, somite-derived follistatin is required for DV patterning in the
spinal cord by preventing dorsalisation of ventral domains by BMPs
(Liem et al., 2000). Our data on the early expression patterns of BMP,
follistatin and FGF3 shows that the expression of the two latter
genes begins earlier that that of BMP4, suggesting that follistatin may
be needed before BMPs in order to ensure the lack of segmental BMP
activity on FGF3 when BMP is starting to be expressed in the
hindbrain. Notably, FGF3 earliest segmental expression is preceding
that of follistatin, suggesting that FGF3 initiation is independent of
BMPs.
Finally, it is possible that there are some overlaps in roles of
follistatin in segmental and DV patterning, in which it both enables
FGF3 expression required for segmentation and underlies segmental
differences in DV speciﬁcation of speciﬁc neurons. Since very little is
known about hindbrain DV speciﬁcation as compared to the trunk,
further analysis of the role and timing of BMP activities in the
hindbrain will be required to distinguish between these possibilities.
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